Isoptin Rr

Verapamil Hydrochloride, the active ingredient in Isoptin Rr, is a calcium channel blocker presented as an oral formulation for oral use. It is employed in the management of hypertension, angina pectoris, and certain cardiac arrhythmias such as atrial fibrillation. GNH USA supplies Isoptin Rr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin Rr acts on the cardiovascular system to control blood pressure and heart rhythm. - Hypertension: lowers systemic arterial pressure by vasodilation. - Angina pectoris: reduces myocardial oxygen demand and improves coronary blood flow. - Atrial fibrillation: slows atrioventricular nodal conduction to help maintain regular rhythm.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness: transient orthostatic changes. - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of skin.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate. - Hypotension: significant drop in blood pressure. - AV block: impaired atrioventricular conduction requiring monitoring.

Careful assessment and monitoring are required when using Isoptin Rr. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Cardiac function review: evaluate for existing heart block or heart failure. - Concomitant beta‑blocker use: increase risk of bradycardia and AV block. - Hepatic impairment: consider dose adjustment due to altered metabolism. - Abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Verapamil may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Beta‑blockers: additive bradycardia and AV block. - Digoxin: increased serum digoxin concentrations. - Diltiazem: enhanced risk of conduction disturbances.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may raise verapamil levels. - Statins metabolized by CYP3A4 (e.g., simvastatin): increased risk of myopathy.